GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.

RPEP-052902021Borner, Tito; Geisler, Caroline E; Fortin, Samantha M; Cosgrove, Richard; Alsina-Fernandez, Jorge; Dogra, Mridula; Doebley, Sarah; Sanchez-Navarro, Marcos J; Leon, Rosa M; Gaisinsky, Jane; White, Arianna; Bamezai, Ankur; Ghidewon, Misgana Y; Grill, Harvey J; Crist, Richard C; Reiner, Benjamin C; Ai, Minrong; Samms, Ricardo J; De Jonghe, Bart C; Hayes, Matthew R

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.

Diabetes, 70(11), 2545-2553

View on PubMed ↗Publisher’s paper ↗

Citation

Borner, Tito; Geisler, Caroline E; Fortin, Samantha M; Cosgrove, Richard; Alsina-Fernandez, Jorge; Dogra, Mridula; Doebley, Sarah; Sanchez-Navarro, Marcos J; Leon, Rosa M; Gaisinsky, Jane; White, Arianna; Bamezai, Ankur; Ghidewon, Misgana Y; Grill, Harvey J; Crist, Richard C; Reiner, Benjamin C; Ai, Minrong; Samms, Ricardo J; De Jonghe, Bart C; Hayes, Matthew R. (2021). GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.. Diabetes, 70(11), 2545-2553. https://doi.org/10.2337/db21-0459